Cardiac risk in the treatment of breast cancer: assessment and management

Código QR

Cardiac risk in the treatment of breast cancer: assessment and management

Antonis Valachis,1 Cecilia Nilsson2 1Centre for Clinical Research Sörmland, Uppsala University, Eskilstuna, Sweden; 2Center for Clinical Research, Västmanlands County Hospital, Västerås, Sweden Abstract: As the number of long-term breast cancer survivors has in...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Valachis A, Nilsson C
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/ab8433f1ba2449d19c6062e18f76802a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Management of early breast cancer in older women: from screening to treatment
por: Elomrani F, et al.
Publicado: (2015)

Risk of primary lung cancer after adjuvant radiotherapy in breast cancer—a large population-based study
por: Anna-Karin Wennstig, et al.
Publicado: (2021)

The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk
por: Thomas P. Slavin, et al.
Publicado: (2017)

Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial
por: Holly Keane, et al.
Publicado: (2021)

Benefits of multidisciplinary teamwork in the management of breast cancer
por: Taylor C, et al.
Publicado: (2013)

Emerging targeted combinations in the management of breast cancer
por: Lee RJ, et al.
Publicado: (2013)

Tamoxifen for women at high risk of breast cancer
por: Nazarali SA, et al.
Publicado: (2014)

New approaches in the management of advanced breast cancer &ndash; role of combination treatment with liposomal doxorubicin
por: Iain RJ Macpherson, et al.
Publicado: (2009)

Breast cancer in Brazil: epidemiology and treatment challenges
por: Cecilio AP, et al.
Publicado: (2015)

Optimal management of bone metastases in breast cancer patients
por: Wong MH, et al.
Publicado: (2011)

Evaluation of multiple transcriptomic gene risk signatures in male breast cancer
por: Jane Bayani, et al.
Publicado: (2021)

Exercise after breast cancer treatment: current perspectives
por: Dieli-Conwright CM, et al.
Publicado: (2015)

Profile of neratinib and its potential in the treatment of breast cancer
por: Feldinger K, et al.
Publicado: (2015)

Cardiac Dose Control and Optimization Strategy for Left Breast Cancer Radiotherapy With Non-Uniform VMAT Technology
por: Jianjian Qiu PhD, et al.
Publicado: (2021)

Decreased risk of breast cancer associated with oral bisphosphonate therapy
por: Mathew A, et al.
Publicado: (2012)

Risk stratification with Breast Cancer Index for late distant recurrence in patients with clinically low-risk (T1N0) estrogen receptor-positive breast cancer
por: Brock Schroeder, et al.
Publicado: (2017)

Challenges in the development of future treatments for breast cancer stem cells
por: Shyam A Patel, et al.
Publicado: (2010)

Role of pertuzumab in the treatment of HER2-positive breast cancer
por: Hubalek M, et al.
Publicado: (2012)

Breast cancer causes and treatment: where are we going wrong?
por: Seymour CB, et al.
Publicado: (2013)

New developments in the treatment of HER2-positive breast cancer
por: Nahta R
Publicado: (2012)

Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ
por: Mathilde M. M. Almekinders, et al.
Publicado: (2021)

The impact of mammographic screening on the subsequent breast cancer risk associated with biopsy-proven benign breast disease
por: Francisco Beca, et al.
Publicado: (2021)

Critical analysis of the potential for microRNA biomarkers in breast cancer management
por: Graveel CR, et al.
Publicado: (2015)

The expanding role of pertuzumab in the treatment of HER2-positive breast cancer
por: Moya-Horno I, et al.
Publicado: (2015)

Preserving fertility in patients undergoing treatment for breast cancer: current perspectives
por: Moffat R, et al.
Publicado: (2014)

Clinical evidence of the efficacy of everolimus and its potential in the treatment of breast cancer
por: Saksena R, et al.
Publicado: (2013)

Palbociclib: an evidence-based review of its potential in the treatment of breast cancer
por: Cadoo KA, et al.
Publicado: (2014)

Role of trastuzumab emtansine in the treatment of HER2-positive breast cancer
por: Oostra DR, et al.
Publicado: (2014)

Potential of afatinib in the treatment of patients with HER2-positive breast cancer
por: Geuna E, et al.
Publicado: (2012)

Risk of hematologic malignancies after breast ductal carcinoma in situ treatment with ionizing radiation
por: Kang Wang, et al.
Publicado: (2021)

Update on raloxifene: role in reducing the risk of invasive breast cancer in postmenopausal women
por: Vogel VG
Publicado: (2011)

EGFR may couple moderate alcohol consumption to increased breast cancer risk
por: Christopher P Mill, et al.
Publicado: (2009)

Aromatase inhibitors in the treatment of breast cancer in post-menopausal female patients: an update
por: Schneider RE, et al.
Publicado: (2011)

Role of lapatinib alone or in combination in the treatment of HER2-positive breast cancer
por: Hurvitz SA, et al.
Publicado: (2012)

Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum]
por: Criscitiello C, et al.
Publicado: (2018)

Aromatase inhibitor-associated bone loss and its management with bisphosphonates in patients with breast cancer
por: Bauer M, et al.
Publicado: (2012)

Identifying patients at high risk of breast cancer recurrence: strategies to improve patient outcomes
por: Martei YM, et al.
Publicado: (2015)

Inherited predisposition to breast cancer in the Carolina Breast Cancer Study
por: Tom Walsh, et al.
Publicado: (2021)

Protein truncating variants in FANCM and risk for ER-negative/triple negative breast cancer
por: Paolo Peterlongo, et al.
Publicado: (2021)

Trastuzumab emtansine in the treatment of HER2-positive metastatic breast cancer in Japanese patients
por: Sawaki M
Publicado: (2014)